Proliferative and differentiative signals required for expression of helper and cytolytic T cell functions have been increasingly discerned through analysis of a family of multiple and functionally distinct monocyte-and lymphocyte-derived interleukins (1) (2) (3) (4) (5) (6) (7) (8) . Antigen-nonspecific cofactors also affect B cells and a complex series of differentiative and growth factors (9) have been identified as requisite signals in the antigen-initiated sequence that culminates in clonal expansion and antibody secretion. In contrast, the identity and role of such soluble factors in the expression of suppressor T cell (Ts) * effector function are poorly understood. Interleukin 2 (IL-2) appears to be an obligate stimulus to the proliferation of helper/inducer (10, 11) and cytolytic (5-8) T cells, as well as natural killer cells (11, 12) ; in addition, culture supernates that contain IL-2 also support Ts growth (11, [13] [14] [15] [16] . However, studies involving the fungal metabolite cyclosporin A (CsA) suggest that Ts may have distinct or additional interleukin requirements in comparison with those of helper or cytolytic T cells. Interference with IL-2 production (17) (18) (19) (20) , possibly in concert with effects on IL-2 receptor display (20) (21) (22) and IL-1 generation (17, 19) , appears to underlie CsA-mediated interference with helper and cytolytic T cell activation (17, (23) (24) (25) . In contrast, Ts function is unaffected (20, 23, 26, 27) , implying that Ts may use additional interleukins produced through CsA-resistant mechanisms.
Thus, to define specific and possibly unique features of differentiative and proliferative signals required by Ts, we have developed a Ts costimulator assay. Initial studies using this assay have identified an antigen-nonspecific, genetically unrestricted soluble factor that is required, in addition to specific alloantigens on fixed stimulator cells, for the activation of alloantigen-primed Ts, designated MLR-Ts and characterized in previous studies (28) . Ts costimulator activity has been identified in primary mixed leukocyte reaction (MLR) supernates and is This work was supported by U. S. Public Health Service grants AI13810 and AI17048. Computational assistance was provided by the CLINFO Core Facility, U. S. Public Health Service grant RR00350.
both irradiated and fixed stimulator cells were resuspended to 40 X 106/ml in supplemented MEM-2% FCS. Additional treatment of fixed cells with irradiation before or after fixation provided results identical to those achieved with fixation alone. Equal numbers of primed MLR-Ts-containing spleen cells and irradiated or fixed stimulator cells were combined, usually 20 × 106 of each, in a total volume of 1.0 ml, and an equal volume of control medium or Ts costimulator-containing preparation was added in varying concentrations. MLR supernates were typically used at 1:2 and EL4 supernates at 1:100 final concentration. These cultures were incubated for 48 h at 37°C in 10% CO2, 83% N2, and 7% 02 and supernates were harvested by centrifugation at 2,500 rpm and stored at -70°C until assay for MLR-TsF activity, a period usually <2 wk. Negative control cultures contained unprimed cells with syngeneic irradiated stimulators and control medium. Additional controls included control or Ts costimulator-containing supernates incubated 48 h as above in the absence of suppressor and stimulator cells. Primed MLR-Ts are designated in the text as the MLR-Ts strain followed by a superscript indicating the allogeneic priming strain (e.g., BALB~6).
Proliferation in Ts costimulator assays was assessed by parallel culture of triplicate or quadruplicate 0.2-ml aliquots of the MLR-Ts stimulator/MLR supernate mixtures that were cultured for MLR-TsF production. Cultures were incubated for 72 h under conditions used for MLR-TsF production, with 1 #Ci [3H]thymidine ([SH]TdR) added during the final 18 h. Cultures were harvested and processed for liquid scintillation counting as described below for MLR assays.
Antibody and Complement Depletion of MLR-Ts Cells.
Viable, primed MLR-Ts-containing spleen cells prepared by LISM and Tris-NH4CI buffer treatment were incubated at 20 x 106/mi with monoclonal anti-Thy-l.2 (1:30), anti-Lyt-l.2 or -2.2 (1:500), or anti-I-J d (I:100) antibodies at 4°C for 30 min and washed once. They were resuspended at 20 x 106/ml in prescreened young rabbit serum (1:10) as a complement source, obtained through the generosity of Dr. R. Baughn, Veterans Administration Medical Center, Houston, TX, and were incubated for 45 min at 37°C. After all cells were washed once, cells exposed to anti-Thy-l.2 and anti-Lyt antibodies were treated a second time with antibodies and complement as before, and all treated groups were washed two to three additional cycles, depleted of dead cells by LISM treatment, and remaining viable cells resuspended as above for culture with irradiated or fixed stimulator cells for MLR-TsF production.
Assay of MLR-TsF in MLR cultures
. MLR cultures in a final volume of 0.2 ml were established in 96-well flat-bottom microtiter plates with 106 each of responder and irradiated (1,500 rad) stimulator cells in supplemented MEM with 10% FCS and 0.1 ml of medium, control factor, or MLR-TsF in multiple concentrations. MLR responder cell strains were always H-2 syngeneic with the MLR-TsF-producing strain. MLR cultures were incubated at 37°C in 10% CO2, 83% N~, and 7% 02 for 96 h, with 1 ~Ci [3H]TdR (sp act, 2 Ci/mmoi; New England Nuclear) added during the final 18 h. Cultures were harvested onto glass fiber filters using a MASH II apparatus (M. A. Bioproducts, Bethesda, MD) and processed for liquid scintillation counting. Data are expressed as Acpm + SEM, representing mean cpm of triplicate cultures with stimulator cells allogeneic to the responder cell strain minus mean cpm of cultures with syngeneic stimulator cells. SEM of Acpm are calculated by the formula for the propagation of errors. Percent MLR suppression is calculated as follows: [1 -(Acpm of MLR with MLR-TsF)/(Acpm of MLR with medium or control factor)] × 100. cells for 2.5 h at 4°C. Supernates were collected by centrifugation at 2,500 rpm and tested for residual IL-2 activity as above.
Gel Filtration Analysis. MLR supernates were concentrated by Minicon-B15 macrosolute concentration (Amicon Corp., Danvers, MA), dialyzed against 0.01 M PBS buffer, and fractionated on a 1.6 × 100-cm calibrated Sephadex G 100 column (Pharmacia Fine Chemicals, Uppsala, Sweden) equilibrated in 0.01 M PBS. 3-ml fractions were collected, dialyzed against culture medium, and assayed for IL-2 and Ts costimulator activity as above.
Results

Activation of MLR-TsF Production in a Ts
Costimulator Assay. A short-term Ts cell costimulator assay was developed to identify stimuli required for Ts cell activation to TsF production. This assay was based on previous observations that glutaraldehyde-fixed stimulator cells fail to trigger the production of MLR-TsF normally obtained from primed MLR-Ts cultured with irradiated or mitomycin C-inactivated stimulator cells (32) . It was possible that fixation prevented an activity in the stimulator cell population that was required for primed MLR-Ts proliferation or differentiation, and that was distinct from the display of alloantigen, which is thought to be largely unaffected (33) . Thus, various cell culture supernates were tested for a soluble factor(s) that would reconstitute the missing stimulus and promote MLR-TsF production when added to primed MLR-Ts and fixed stimulator cells. In Fig. 1 
Specificity Characterization of Ts Costimulator Activity in Primary MLR Superhates.
To characterize antigen specificity of Ts costimulator activity, supernates were harvested from primary MLR composed of various responder and stimulator strains or of stimulator cells alone and examined for costimulator activity in relation to MLR-Ts stimulator ailoantigens (Table I) . BALB a6 MLR-Ts cultured with fixed B6 stimulator cells produced substantial MLR-TsF with the addition of BALB anti-B6 MLR supernate but not with supernates of unstimulated BALB splenocytes or of B6 stimulators cultured alone. Primary MLR supernates prepared in response to H-2 and minor alloantigens identical to or distinct from those used to prime and restimulate MLR-Ts each expressed effective Ts costimulator activity with B6-primed BALB MLR-Ts. Similarly, MLR supernates prepared with responder cells identical to or dissimilar from the MLR-Ts strain with regard to H-2 or non-H-2 (including Igh) genotype were also equally effective. Thus, neither strain restriction nor alloantigen specificity limit the Ts costimulator property. MLR-Ts-stimulator strain combinations other than BALB anti-B6 provided similar results (data not shown). Again, none of the primary MLR supernates were directly suppressive of assay MLR. In addition, MLR-Ts precursors from unprimed rather than primed BALB spleens were not induced to significant TsF production within the 48-h culture period in the presence of either syngeneic or allogeneic fixed stimulators and Ts costimulatorcontaining MLR supernate. Together these findings differ from characteristics reported for Ts inducer or first-order Ts factors, including antigen specificity, VH restriction, and the induction of Ts from unprimed precursors (34) . Instead, Ts costimulator characteristics suggest a closer alignment with the lymphocyteand monocyte-derived family of interleukins.
MLR-Ts Population Requirements for Expression of Ts Costimulator Activity. Ts
costimulator activity results in the release of MLR-TsF, a product of Thy-1 +, Ly-2 +, I-J+C + lymphocytes (35, 36) . To determine if Ts costimulator expression directly or indirectly requires an intermediary Ly-l+2 -cell, primed MLR-Tscontaining spleen cells were depleted of cell subsets by antibody and complement lysis and remaining viable cells were cultured for MLR-TsF production with fixed stimulators and primary MLR supernates (Table II) . Absence of Thy-1 +, Ly-2 ÷, or I-J + cells from the MLR-Ts population prevented MLR-TsF production. In contrast, Ts costimulator-induced MLR-TsF production was unaffected by the depletion of cells bearing abundant Ly-1, suggesting that the expression of Ts costimulator activity does not require this population of Ly-1 + cells or their soluble products. assay (Fig. 2 ). Unadsorbed 48-h primary MLR supernates typically expressed modest IL-2 activity (Fig. 2, inset ) and did not contain material suppressive of IL-2 utilization (legend, Fig. 2 ). HT2 adsorption removed IL-2 activity, but failed to diminish Ts costimulator function; HT2-adsorbed MLR supernate or control medium were not directly suppressive. Thus Ts costimulator and IL-2 activities appear to be distinct. An alternative approach was developed from the observation that CsA prohibits IL-2 production (17) (18) (19) (20) , yet permits Ts function (20, 23, 26, 27) . Supernates were collected from BALB anti-B6 MLR that were cultured in the absence or presence of CsA, dialyzed extensively, and assayed for IL-2 and Ts costimulator activity (Fig. 3) . Supernates prepared with CsA lacked IL-2 activity while the MLR-Ts-activating property was unaffected. MLR supernates prepared with CsA or culture medium incubated with CsA (data not shown) were not directly suppressive. These data again strongly suggest that Ts costimulator activity is distinct from IL-2; moreover, Ts costimulator production appears to be resistant to CsA and may contribute to the protected development of Ts in its presence.
The relationship of IL-2 and Ts costimulator activities was also characterized by gel chromatography (Fig. 4) . Concentrated BALB anti-B6 MLR supernate was applied to a G100 column and collected fractions were dialyzed against culture medium and tested for IL-2 activity by HT2 proliferation at multiple dilutions and for MLR-Ts costimulator activity at a I:2 final dilution. eluted in the 28-32,000 tool wt region while two peaks of 19,000-23,000 and 40,000-45,000 mol wt contained costimulator activity; a shoulder ofcostimulator activity at 28,000 tool wt was approximately coincident with the IL-2 peak. None of the MLR supernate fractions were suppressive when added directly to assay M LR, and G 100-chromatographed control M LR culture medium containing 5% FCS neither contained Ts costimulator activity nor directly suppressed assay MLR (data not shown). Thus, Ts costimulating activity exists in two major peaks of approximately 21,000 and 43,000 mol wt that are largely independent of IL-2-containing fractions.
Expression of Ts Costimulator Activity in EL4
Supernates. The supernates of PMA-induced EL4 thymoma cells are a potent source of IL-2 activity, and distinct B cell reactive lymphokines have also been identified in these supernates (9, 39) . Thus it was of interest to determine if standard EL4 supernates also contained Ts costimulator activity and if this activity could be differentiated from IL-2. MLR-Ts costimulator assays were established with MLR supernates or with dilutions of a standard EL4 supernate. After 48 h, the MLR-Ts culture supernates were harvsted, adsorbed with HT2 cells to remove residual IL-2, and assayed for MLR-TsF activity (Fig. 5) ; as demonstrated in previous studies (31) and confirmed here, HT2 adsorption of conventional MLR-TsF does not inter- studies, HT2-adsorbed EL4 supernates were not suppressive when added directly to assay MLR (data not shown).
To determine if the Ts costimulator activity in EL4 supernates was the result of IL-2 or of a distinct material, EL4 supernates were adsorbed with HT2 cells to remove IL-2 before their addition to the MLR-Ts costimulator assay (Fig. 6) . As with HT2-adsorbed MLR supernates, IL-2-depleted EL4 preparations clearly expressed substantial Ts costimulator activity. Although these experiments do not address the role that IL-2 may also play, it appears evident that a material expressing MLR-Ts costimulator activity and distinct from IL-2 exists in EL4 supernates.
Ts Costimulator Activity in the Absence of MLR-Ts Proliferation.
In an initial approach we wished to examine the nature of the Ts costimulator function(s), i.e., proliferative or differentiative, that supports activation of MLR-Ts. If the primary function is proliferation of the MLR-TsF-producing cell pool, it would be anticipated that the expression of Ts costimulator activity would be inhibited by prevention of response to proliferative signals. Therefore MLR supernates were added to Ts costimulator assays in which the BALB B6 MLR-Ts population was either irradiated (1,500 rad) or untreated (Fig. 7) . Ts costimulator activity was assayed by MLR-TsF production, and MLR-Ts proliferation was assessed by production by irradiated MLR-Ts was decreased but still clearly present in positive control cultures with irradiated stimulator ceils. Significantly, the capacity of Ts costimulator to induce TsF production was unaltered by irradiation of the MLR-Ts population. These data imply a costimulator function that does not act via proliferative stimulus, but rather appears to reflect the induction of a differentiative process required for TsF secretion. For simplicity of reference, the MLR-Ts costimulating activity represented in primary MLR supernates has been provisionally termed Ts differentiation factor (TsDF).
Discussion
In this report we describe a Ts costimulating factor that synergizes with alioantigens on fixed stimulator cells to induce MLR-TsF production by alloantigen-primed MLR-Ts. Based on several functional criteria the Ts costimulating property appears to be distinct from the class of soluble factors with antigenspecific, Ts-inducing qualities, and instead to be most closely associated with the regulatory interleukins. Functional and molecular weight characteristics differentiate Ts costimulator in both primary MLR and induced EL4 supernates from the T cell lymphokine IL-2, and indirect evidence discussed below suggests distinction from IL-I and gamma interferon (IFN-7) as well. Thus the Ts costimulator factor(s) described here, and specifically the differentiative activity termed TsDF, may constitute distinctive members of the family of interleukins required in the antigen-driven activation of Ts to effector function. In several murine and human suppressor T cell systems, primed and restimulated T cells termed, alternatively, suppressor inducers (Tsi) or first-order suppressor cells (Tsl), or their soluble products, induce a subset of T cells to effector suppressor activity from unprimed precursors (40) (41) (42) (43) (44) (45) (46) (47) (48) . In so doing they impart antigen specificity to the induced Ts, either for the antigen used to stimulate the Tsi (40, 41) or for determinants serologically described as idiotypic and assumed to exist on the Tsi antigen-binding receptor (42) (43) (44) . Additional specificity of Ts inducer-Ts precursor interaction may be imposed by Vu restrictions (40) . Soluble products of murine Tsi express antigen-binding sites, idiotypic or V. determinants, and in most cases I-J determinants (34); from affinity column analyses these determinants exist on a molecule(s) both required and sufficient to initiate Ts function (41, (45) (46) (47) . These inducer molecules may provide the antigenic and perhaps the major histocompatibility complex-encoded elements required to initiate Ts precursor activation; clearly, they are distinct from the antigen-nonspecific, nonrestricted, hormone-like factors classified as interleukins. Similarly, the Ts costimulator preparations described here are also distinct from Ts-inducing factors in several respects, including lack of antigen specificity and genetic restriction, production early in a primary response rather than after priming and restimulation, and failure to activate naive Ts. BALB/ c B~ MLR-Ts activation was achieved with Ts costimulator preparations that violate both H-2 (CBA, SJL, DBA/1 costimulator sources) and IgH (B10.D2, DBA/1, SJL sources) restrictions. In addition, although the alloantigenic stimuli of MLR-Ts and of Ts costimulator production are each potentially complex, no general strain-associated alloantigen specificity of Ts costimulator effect was apparent. Moreover, Ts costimulator promotes ~ctivation of primed but not naive Ts within the limited time frame analyzed, while Ts-inducing factors generally fail to affect primed Ts (44, 49, 50) . These qualities thus appear to characterize Ts costimulator activity as a function of an interleukin-like material and distinguish it from the antigen-specific Ts inducers.
The interpretation that Ts costimulator activity is mediated by molecules distinct from IL-2 is supported by each of the approaches to determining the relationship of these two activities. Thus Ts costimulator function is retained in HT2-adsorbed, IL-2-deficient supernates, is generated in cultures in which IL-2 production is blocked by CsA, and demonstrates distinct molecular weight characteristics. Moreover, proliferation is not required for Ts costimulator expression. The presence of Ts costimulator activity as a component of EL4 supernate distinct from IL-2 is additionally interesting in light of the recent identification of an 18,000 mol wt fraction containing a B cell growth factor (BCGF) (39) and a late-acting B cell differentiative cofactor termed EL4-TRF (9) in PMA-induced supernates of the same EL4 subline. The relationship of Ts costimulator to these B cell-related cofactors, or to other characterized T cell and macrophage-derived factors has not yet been directly examined, although the reported susceptibility of IL-I (17, 19) and IFN-3, (51) production to CsA suggest that these factors are not mediators of the Ts costimulation described in this report. In addition, the present studies do not yet allow the conclusion that the material in EL4 supernates and that characterized in primary MLR supernates are biochemically or functionally identical. Each demonstrates Ts costimulator activity but may achieve that activity by distinct mechanisms. Moreover, it is not clear if the MLR supernate-derived 43,000 and 21,000 mol wt fractions expressing costimulator activity represent distinct species or complexed forms of a single molecule. Finally, although this Ts costimulator activity is not apparently mediated by IL-2, additional roles of IL-2 or other lymphokines in support of the process of MLR-Ts activation to TsF production have not been directly approached in these studies and are clearly possible. Complex IL-2-rich culture supernates have been used in the promotion of Ts activity (37, 38) and maintenance of long-term Ts lines (11, 13-16); however, Ts utilization of I L-2 per se as a proliferative trigger has not yet been formally demonstrated.
The production of Ts costimulator in the presence of CsA has interesting implications concerning interleukin stimuli that contribute to Ts function. Although CsA effects appear to be complex and somewhat controversial, it is generally appreciated that CsA prohibits IL-2 production by alloantigen-activated T cells (17) (18) (19) (20) ; as previously stated, it appears that the generation of IFN-~, (51) and IL-1 (17, 19) are also interrupted. In contrast, Ts costimulator is produced in primary MLR cultures in the presence of CsA, and in the absence of IL-2. Activation of Ts costimulator-producing cells thus appears to be CsA resistant and to occur in the absence of both IL-1 and IL-2 differentiative and proliferative support. Hess et al. (52) and more recently Mohagheghpour et al. (53) have demonstrated T4 ÷ or Leu-3+8 + cells, respectively, in CsA-suppressed MLR of human cells, which appear to be required for expression of T8 ÷ suppressor cell function. Such cells thus may be the CsA-resistant producers of Ts-associated factors such as the Ts costimulator described here.
An alloantigen-primed MLR-Ts population and fixed stimulator cells bearing priming alloantigens are required in the Ts costimulator assay. It is clear that alloantigen recognition by primed cells is necessary for interaction with Ts costimulator and is achieved with glutaraldehyde-fixed stimulators. Thus antigen binding may trigger the expression of TsDF or other Ts costimulator-specific receptors on primed MLR-Ts, allowing subsequent cofactor interaction. In the absence of Ts costimulator, activation to MLR-TsF production fails regardless of stimulator cell concentration, indicating that fixation has impaired an additional and requisite stimulator cell function distinct from surface antigen display. MLR-Ts typically interact with stimulator cells of novel I-C + or I-J+C ÷ phenotypes (54) . Whether Ts costimulator directly represents an activity of such a stimulator cell or rather the product of a secondary cell that requires stimulator cell interaction is presently unclear. Furthermore, the immediate target of Ts costimulator in the primed MLR-Ts-containing population has not been directly established in these studies. It is evident that T cells bearing abundant Ly-I alloantigen and routinely removed by anti-Ly-1 antibody-mediated lysis are not target cell candidates. In addition, under usual conditions of MLR-Ts reactivation, MLR-TsF production is insensitive to rigorous macrophage depletion of both MLR-Ts and stimulator populations (32) , suggesting indirectly that these cells are also unlikely Ts costimulator targets. Similarly, based on depletion protocols, B cells play no requisite role in MLR-Ts activation (S. Rich and C. Arhelger, unpublished observations). Thus the most likely although unproven target exists in the Ly-2 ÷, I-J+C + MLR-Ts population. The observation that primed but not unprimed cells are responsive t ° Ts costimulator in concert with alloantigen may reflect the expression of a late-appearing cofactor requirement, presumably differentiative, for the final expression of Ts effector function. Alternatively, this cofactor requirement may be more generally expressed after antigen recognition and simply require extended culture of unprimed cells for measurable effect.
Production of MLR-TsF is the endpoint of Ts cofactor activity defined by this costimulator assay. An ordered and complex series of interleukin-mediated differentiative and proliferative events have been described after initial antigenreceptor interaction in the functional development of IL-2-producing helper T cells, cytotoxic T lymphocytes, and antibody-producing B cells. It is likely that Ts will demonstrate a similar scheme of activation. In this initial characterization, unfractionated MLR supernates minimally contain a Ts cofactor that fulfills a differentiative requirement of antigen-activated MLR-Ts. It will now be of substantial interest to examine the contributions of purified TsDF, IL-2, and other differentiative and proliferative cofactors in control of Ts activation to effector function.
Summary
This report describes a Ts costimulator assay and its use to analyze cofactors required for the expression of suppressor T cell function. Activation of primed MLR-Ts (alloantigen-activated suppressor T cells suppressive of mixed leukocyte reaction) to suppressor T cell factor (TsF) production typically fails in the presence of glutaraldehyde-fixed rather than irradiated allogeneic stimulator cells. However, MLR-TsF production was restored by the addition of 48-h primary MLR supernates; MLR-derived Ts costimulator neither activated primed MLR-Ts in the absence of fixed allogeneic stimulators nor directly suppressed assay MLR. Lack of antigen specificity or genetic restriction and failure to activate unprimed MLR-Ts precursors suggested that Ts costimulator activity differed from previously described Ts inducer functions and was more closely aligned with the lymphocyte-or monocyte-derived interleukins (IL). Three findings distinguished Ts costimulator from IL-2. Depletion of IL-2 activity from MLR supernates by HT2 adsorption failed to affect Ts costimulator function. In addition, MLR supernates prepared in the presence of cyclosporin A contained no IL-2 but expressed Ts costimulator activity. Finally, gel chromatography demonstrated Ts costimulator in peaks of 21,000 and 43,000 moi wt that were largely distinct from the IL-2-containing fractions. Ts costimulator activity was also identified in phorbol myristate acetate (PMA)-induced EL4 supernates and was retained in those supernates after IL-2 depletion by HT2 adsorption. In preliminary functional characterization, MLR supernate-derived Ts costimulator triggered MLR-TsF production from irradiated MLR-Ts in the absence of proliferation. Thus a differentiative rather than proliferative stimulus required for primed MLR-Ts function appears to be provided by this Ts costimulator and has been provisionally termed Ts differentiative factor (TsDF). This initial characterization may thus identify one of a possibly distinctive family of interleukins required in the alioantigen-driven activation of suppressor T cells to effector function.
